HoPMOp – Hospital Pharmacy and Medicines Optimisation Project
Posted in News
A new node and suite of reports [Benchmark > HoPMOp Indicators] has been created for the reports that are anticipated to be the most widely used by trusts demonstrating compliance with HoPMOp – the Hospital Pharmacy and Medicines Optimisation Project.
Specifically, among others, we have created reports to monitor:
- Use of soluble prednisolone versus total prednisolone
- Use of biosimilars of infliximab and etanercept
- Total spend on etanercept
- Total antibiotics consumption in defined daily doses (DDD) per 1,000 admissions.
Further reports will be created and added to this node as HoPMOp develops.